GQC Editorial Board
GQC Editorial Board
Share this article

GQC – Global Quality Cannabis – the new Start-up to support the Medical Cannabis Industry

PQE Group is pleased to announce the launch of GQC – Glocal Quality Cannabis. The newly created company is the world’s first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution. GQC is part of the PQE Group federation, a world leading quality solution provider for the Life Science industry with almost 25 years of expertise in providing solutions to major companies in the Life Science industry all over the world, supporting organizations ranging from start-ups to large pharma by acting locally with a global mindset.

Thanks to the significant knowledge gained by PQE Group over more than two decades, GQC is able to provide first class services covering the complete product’s life cycle: Engineering, GxP quality compliance, regulatory affairs, medical-scientific advisory, clinical studies and a GQC academy.

Even if the market still struggles with fragmented and sometimes obscure national legislation, GQC has developed an innovative proposal that precisely fits in: apply the highest international standards at a local level to always guarantee efficacy, safety, and quality to the end patient.

Riccardo Salvagnini, GQC VP Executive commented – “I believe that medical cannabis should be treated the same as any other pharmaceutical product. Our vision is to support the development of new therapies through effective management of data quality by accelerating the registration of cannabis products and reducing the timing of the supply chain to be faster for the patients.” Salvagnini continues, “We want to provide effective technological solutions to medical cannabis products to accelerate the go-to-market strategy through a local approach but with a global mindset. Our quality services support each process and technology to navigate regulations worldwide and provide access to medicines faster and more efficiently. Too often still,” Salvagnini concludes, “patients still have difficulty finding these drugs due to a lack of availability of the raw material, which undermines their right to access care.”

The GQC Team is ready to support your business in achieving the highest standards of quality and bringing your product to market, connect with our experts to explore customized solutions for your needs.

Related Publications

Discover more about this topic and get the latest updates about the cannabis industry.